Injective, a prominent player in the cryptocurrency market, is making concerted efforts toward innovation and growth. The platform has unveiled a
No-Code platform for Web3 builders, embodying their commitment to enabling transformative technologies and facilitating a new era of Web3 development. However, not everything is smooth sailing as, despite a 14% climb in Injective's
total value locked (TVL), the
INJ token recently slipped by 8%. Injective is preparing for a token burn event in October, presumably aimed to address this. Moreover, BlockchainFX ($BFX) is looking to replicate Injective's pathway to success and become a compelling altcoin. Injective is also making strides with its ambitious
exchange-traded fund (ETF) project. The proposal from Canary has now reached the public input phase with the Securities and Exchange Commission (SEC). This move signals growing demand for altcoin funds. Additionally, Pineapple Financial launched the first corporate Injective Treasury with a significant $100M investment. As per price predictions,
Injective (INJ) could reach a new all-time high this year. Such market optimism is further asserted by a considerable buy amounting to $8.9M. The platform also announced the launch of perpetual futures for major pre-IPO companies like OpenAI.
Injective continues to find favour, as demonstrated by a first staked ETF filing by asset manager
Canary Capital. Parallelly, Injective hit Wall Street with a considerable $100M public treasury launch. More recently, the INJ token experienced an uptick in price, nearing a resistance level of $16.42 and exhibiting potential for a bullish breakout.
Injective Coin News Analytics from Tue, 27 Jul 2021 07:00:00 GMT to Wed, 05 Nov 2025 14:05:24 GMT -
Rating 4
- Innovation 5
- Information 7
- Rumor -2
